TrialNature metabolism2024

Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology.

Chinmay Dwibedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.